Menu
Back to Journals » Biologics: Targets and Therapy
Biologics: Targets and Therapy
ISSN: 1177-5491
Editor-in-Chief: Dr Doris Mangiaracina Benbrook
ISSN: 1177-5475 (Print) - went to online only in 2009
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (455)
- Volume 15, 2021 (34)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Latest articles:
- 5 records -
Stem Cell Therapy for Burns: Story so Far
Abdul Kareem N, Aijaz A, Jeschke MG
Biologics: Targets and Therapy 2021, 15:379-397
Published Date: 31 August 2021
Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
Madani A, Almuhaideb Q
Biologics: Targets and Therapy 2021, 15:375-378
Published Date: 1 September 2021
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG
Biologics: Targets and Therapy 2021, 15:363-374
Published Date: 27 August 2021
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie MA, Wondimu BZ
Biologics: Targets and Therapy 2021, 15:353-361
Published Date: 21 August 2021
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
Findeisen KE, Sewell J, Ostor AJK
Biologics: Targets and Therapy 2021, 15:343-352
Published Date: 12 August 2021